Cellino

?? Today marks an extraordinary milestone at Cellino! We are thrilled to announce that our team has been awarded up to $25M in funding from the Advanced Research Projects Agency for Health (ARPA-H), an agency within the U.S. Department of Health and Human Services (HHS). This funding will drive the development of our ultra-scalable, autonomous, cassette-based advanced biomanufacturing technology for personalized regenerative medicine. Cellino’s NEBULA (NExt-generation Biomanufacturing ULtra-scalable Approach) project is the first project funded by the Scalable Solutions Mission Office under the ARPA-H Open Broad Agency Announcement. With ARPA-H’s support, Cellino will build a cassette-based biomanufacturing technology capable of scaling the production of personalized induced pluripotent stem cells at hospitals nationwide to develop curative medicines for a range of chronic conditions for an increasingly diverse and aging U.S. patient population. We are excited to move closer to making “Your Cells, Your Cure?” a reality for millions of patients. We are thrilled about this opportunity to advance our goal of making patient-specific stem cell-derived therapies available for broad patient audiences. ?? Read the full release: https://bwnews.pr/4gfrjlb #ARPAH #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenerativeMedicine #BiotechBreakthroughs #CellinoBio #YourCellsYourCure #Biomanufacturing

?? We are honored to have Willie T. Reaves, our Head of Public Engagement, speak at the CPHI Middle East 2024 conference in #Riyadh, Saudi Arabia! Bringing together global leaders in biotechnology, this premier event from December 10–12, 2024, highlights innovation and strategic advancements shaping the future of #healthcare. Willie will speak on December 11, 2024 (Day 2): ?? Keynote Presentation – Next-Gen Bio Stage ??? December 11, 2025 | ? 11:15 - 11:45 AM AST ?? Title: Catalyzing Global Innovation to Extend Healthspan for All ?? Panel Discussion – Future Stage ??? December 11, 2025 | ? 1:20 - 2:05 PM AST ?? Topic: The Future is Bio – Realizing the National Biotechnology Strategy In January 2024, His Royal Highness Prince Mohammed bin Salman bin Abdulaziz Al-Saud launched Saudi Arabia’s National Biotechnology Strategy. Willie will join a distinguished panel to discuss the strategy’s ambitions, addressing the opportunities and challenges in bringing this vision to fruition. Moderator Ivo de Maddalena of NEOM will lead the discussion featuring the following panelists: - Dr. Khalid Alburikan, Strategic Advisor to His Excellency the Vice Minister of Health for Planning and Development and Head of Biotechnology Portfolio - Claudia Palme, Senior Executive Advisor, Strategy&, part of the PwC Network - Dr. Abdelali Haoudi, Executive Director, King Abdullah International Medical Research Center (?????? KAIMRC) - Bj?rn Zoega, Deputy CEO, King Faisal Specialist Hospital and Research Center - Professor Sir Edward Byrne AC, President, KAUST (King Abdullah University of Science and Technology) - Kalle K?nd, CEO, MS PHARMA - Willie T. Reaves, Head of Public Engagement, Cellino ?? Explore the full conference agenda and details here: https://lnkd.in/gZ46ygF7 We’re proud to contribute to these conversations and explore the transformative potential of #biotechnology as a catalyst for innovative solutions to improve global health. ???? #CPHI #CPHIMiddleEast #Biotech #AI #MachineLearning #Innovation #Collaboration #FutureOfHealthcare #RegenerativeMedicine #YourCellsYourCure #CellinoBio

??Thank you to everyone who joined us for the 2nd Annual Personalized RegenMed Forum (#PRMForum2024) in #Cambridge, MA! ?? This year’s theme, “Catalyze,” brought together an incredible group of scientists, industry leaders, patient advocates, and technology pioneers from five countries for two days of impactful sessions and workshops on the future of regenerative medicine and curative therapies. Visionary speakers like Vinod Khosla, Founder and Partner of Khosla Ventures, Susan Hockfield,? Ph.D., President Emerita of Massachusetts Institute of Technology, and Chad Cowan, Ph.D., Chief Scientific Officer of Century Therapeutics, Inc, shared invaluable insights on integrating AI into healthcare and improving patient access to transformative treatments. Bringing a valuable patient perspective, Jimmy Choi of The Michael J. Fox Foundation for Parkinson's Research highlighted the importance of keeping patients at the center of therapeutic innovation. On the second day of the Forum, attendees worked collaboratively on shared industry messaging to build unified messaging for the personalized regenerative medicine industry. In a workshop on patient access and reimbursement, leaders explored real-life case studies spanning multiple therapeutic modalities to consider how to maximize patient access to transformative medicines. The ideas shared and collaborations sparked at the Forum have energized us to continue driving this momentum forward. We are committed to shaping the next era of regenerative medicine by addressing today’s challenges and building a future where personalized therapies are accessible to all! ?? Read the full press release for more details about this year’s Forum: https://lnkd.in/ejpKrvyY A special thank you to all the incredible contributors to the 2nd Annual Personalized RegenMed Forum: Sue Siegel, Kapil Bharti of National Eye Institute (NEI) Intramural Research Program, Jen Nwankwo, Ph.D. of 1910 Genetics, Peter Andersen of TreeFrog Therapeutics, Petr Baranov of Massachusetts Eye and Ear, Young-sup Yoon of Karis Bio, Ben Shepherd of Trestle Biotherapeutics, and Darshak Sanghavi of Advanced Research Projects Agency for Health (ARPA-H), and Nabiha Saklayen, Marinna Madrid, PhD, Rebecca "Becky" Kusko, PhD, and Willie T. Reaves Jr. from Team Cellino. #PRMForum #RegenMed #PersonalizedMedicine #PatientAccess #FutureOfHealthcare #EquityinHealthcare #Collaboration #iPSC #CellTherapy #CatalyzeCures #CellinoBio

?? We’re proud to celebrate Willie T. Reaves, our Head of Public Engagement, for his recent appointment as Director of Community Engagement at Biopharma Leaders of Color (BLOC). BLOC is a 501(c)(3) non-profit organization dedicated to advancing representation and leadership for people of color in the biopharmaceutical and life sciences industries. As Director of Community Engagement, Willie will foster impactful connections and drive initiatives that enhance inclusion across the industry. We look forward to seeing the transformative work Willie will accomplish with #BLOC, helping to create a more inclusive future in biotechnology and life sciences. Congratulations, Willie! ?? ?? Read more about BLOC’s expanded leadership team and mission here: https://lnkd.in/e7jb-PUc #BLOC #Biotech #LifeSciences #BiotechLeaders #DiversityInBiopharma #Leadership #FutureOfInnovation #BuildingInclusivity #Cellino

?? The Founder-Led Biotech Tour is back! We’re thrilled to share that our Co-Founder & CEO, Nabiha Saklayen, will be co-hosting the #Boston stop with Pillar VC and other biotech founders and key leaders on Wednesday, November 20. This is a fantastic opportunity to connect with executives, scientists, investors, and ecosystem partners who are shaping the future of biotechnology. Founder-led biotech is a movement built on the idea that many of the best biotech companies are founded by scientists. We’d love for you to join us for an evening of networking and insightful conversations. ??? Date: Wednesday, November 20, 2024 ?? Time: 5:30 PM - 7:30 PM ET ?? Request to join here: https://lnkd.in/gWhS5_4Y We’re looking forward to sharing this experience with you! ?? #PillarVC #CambridgeMA #BostonEvents #Biotech #FounderLedBiotech #Networking #Innovation #CellinoBio #BiotechLeaders #YourCellsYourCure

?? Cellino is thrilled to attend the Jefferies London Healthcare Conference 2024 from November 19–21 in London! Rebecca "Becky" Kusko, PhD, our Chief of Staff & Head of Strategy, will join leading global, public and private companies from the biotechnology and medical technology sectors to discuss current trends driving healthcare around the globe. We look forward to engaging in conversations with key stakeholders and learning about recent advancements that will shape the landscape of global #healthcare! #JefferiesHealthcare #Biotech #AI #MachineLearning #Innovation #PersonalizedMedicine #RegenMed #CellinoBio #YourCellsYourCure

We were honored to have Willie T. Reaves, Head of Public Engagement at Cellino, share our vision at the Precision Health Summit 2024. His perspective on the transformative potential of personalized regenerative medicine highlights the future we’re working toward—one where treatments using a patient’s own DNA offers curative solutions without the risk of immune rejection. Innovations in #automation and #AI are helping to make this vision a reality, accelerating our progress toward accessible, patient-centric healthcare solutions. ????

?? Cellino is excited to attend Mass General Brigham’s 2nd Annual Gene and Cell Therapy Research Symposium from November 12-13, 2024 in #Somerville, MA! Rebecca "Becky" Kusko, PhD, our Chief of Staff and Head of Strategy, is excited to connect with fellow innovators and engage in discussions on advancing cell therapy research for personalized regenerative medicine. We’re looking forward to hearing from keynote speakers like Crystal Mackall of Stanford University School of Medicine and Erik Sontheimer of UMass Chan Medical School, as well as exploring new opportunities for collaboration and innovation! ??? Register for the event here: https://lnkd.in/gM-KNr3n #Biotech #AI #MachineLearning #PersonalizedMedicine #Collaboration #Innovation #RegenMed #RandD #CellinoBio #YourCellsYourCure

?? We’re excited to be here at Cell 2024 by Oxford Global in #London! Our CEO & Co-Founder, Nabiha Saklayen, will be speaking on Cellino’s vision for the future of personalized regenerative medicine on November 7-8. ??? Don’t miss these key sessions: ?? November 7, 2024 | 4:35 PM - 5:25 PM GMT Panel Discussion - Advancing Cell Therapies: Exploring Quality Control & Personalized Medicine Integration ?? Nabiha will speak on a panel featuring Zhong Yu, Scientific Liaisons Manager at Axion BioSystems, Monica Raimo, Director of Product and Process Development at Glycostem Therapeutics, and Nicolas Weber, Quality Team Leader QC at Novartis, moderated by Philippe Henon, Founder & Chairman of the Board at CellProthera SAS. ?? November 8, 2024 at 2:45 PM GMT iPSCs and Stem Cell Therapy Development (Track 4): AI-Driven Biomanufacturing of Cell and Tissue Replacements. ?? Nabiha will present on Cellino’s optical bioprocess, which combines optics and image-guided machine learning for iPSC management, as well as optical cassette-based manufacturing for scalable production of cells and tissues. ?? Explore the full agenda here: https://lnkd.in/gh3MaE7U #OxfordGlobal #NextGenBiomed #Biotech #AI #Innovation #RegenMed #Therapeutics #PersonalizedMedicine #YourCellsYourCure #CellinoBio

?? We’re proud to announce that Jesse Mulcahy, Head of Automation at Cellino, will be a featured speaker at AMG World’s Future Labs, Automation & Technology Summit West in #SanDiego on November 12, 2024! Be sure to attend the following sessions: ?? 11:45 AM – Building the Foundations for the Lab of the Future Jesse will moderate an opening session on developing the infrastructure, hardware, software, and IT support necessary for AI-driven analytics and data processing in labs. ?? 5:30 PM – The Lab of Tomorrow: What’s Emerging for Future Labs and How Can We Plan for the Next Generation of Lab Technology? Jesse will join a panel to discuss the latest innovations in AI, robotics, IoT, and other technologies revolutionizing lab processes. The conversation will explore ways to overcome technical barriers, implement energy-efficient equipment, and use automation to unlock smarter workflows. ?? Panelists including Jesse: Dragan Djordjevic, Director, ML & Digital CMC Cell Therapy Development & Automation, Takeda Kalpesh Gupta, Director of Research Automation, Moderna Join us to stay ahead in lab technology and explore the latest advancements: https://lnkd.in/gJEPAqnK #FutureLabsWest #Automation #LabTechnology #AI #Innovation #Biotech #RegenerativeMedicine #DataAnalytics #CellinoBio #LabOfTheFuture